115 / 1631
•
The immune explosion in oncology – ICI, CAR-T cells
•
Combinatorial immensity
•
Too big to fail
•
Too big (and costly) to succeed?
–
Study design
–
Collaboration
–
Biomarker driven
–
Further scientific discovery required
Patients
Trial
Samples
Science
Academia
Funding
Sources
Pharma
The future of immunoregulation in lymphoma